These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4399038)

  • 21. Crystallographic study of a beta-lactam inhibitor complex with elastase at 1.84 A resolution.
    Navia MA; Springer JP; Lin TY; Williams HR; Firestone RA; Pisano JM; Doherty JB; Finke PE; Hoogsteen K
    Nature; 1987 May 7-13; 327(6117):79-82. PubMed ID: 3646481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atomic coordinates for tosyl-elastase.
    Sawyer L; Shotton DM; Watson HC
    Biochem Biophys Res Commun; 1973 Aug; 53(3):944-51. PubMed ID: 4738720
    [No Abstract]   [Full Text] [Related]  

  • 23. Conformational changes and inhibitor binding at the active site of elastase.
    Shotton DM; White NJ; Watson HC
    Cold Spring Harb Symp Quant Biol; 1972; 36():91-105. PubMed ID: 4508177
    [No Abstract]   [Full Text] [Related]  

  • 24. Three dimensional structure of adenyl kinase.
    Schulz GE; Elzinga M; Marx F; Schrimer RH
    Nature; 1974 Jul; 250(462):120-3. PubMed ID: 4367210
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of porcine pancreatic elastase by 7-substituted 4-chloro-3-ethoxyisocoumarins: structural characteristics of modeled noncovalent complexes relate to the measured inhibition kinetics.
    Plaskon RR; Kam CM; Kerrigan JE; Burgess EM; Powers JC; Suddath FL
    Arch Biochem Biophys; 1993 Feb; 300(2):588-97. PubMed ID: 8434939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of the complex of porcine pancreatic elastase with two valine-derived benzoxazinone inhibitors.
    Radhakrishnan R; Presta LG; Meyer EF; Wildonger R
    J Mol Biol; 1987 Dec; 198(3):417-24. PubMed ID: 3430613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer aided prediction and evaluation of the tertiary structure for rat elastase II.
    Carlson GM; MacDonald RJ; Meyer EF
    J Theor Biol; 1986 Mar; 119(1):107-24. PubMed ID: 3635654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystalline porcine pancreatic elastase.
    Shotton DM; Hartley BS; Camerman N; Hofmann T; Nyburg SC; Rao L
    J Mol Biol; 1968 Feb; 32(1):155-6. PubMed ID: 5642189
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in the tertiary structure of alpha-chymotrypsin with change in pH: p4 4.2-6.7.
    Vandlen RL; Tulinsky A
    Biochemistry; 1973 Oct; 12(21):4193-200. PubMed ID: 4745667
    [No Abstract]   [Full Text] [Related]  

  • 30. Structural and functional role of leucine residues in proteins.
    Chou PY; Fasman GD
    J Mol Biol; 1973 Mar; 74(3):263-81. PubMed ID: 4692853
    [No Abstract]   [Full Text] [Related]  

  • 31. Structural similarities between alpha-lytic protease of Myxobacter 495 and elastase.
    McLachlan AD; Shotton DM
    Nat New Biol; 1971 Feb; 229(7):202-5. PubMed ID: 4996244
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure of porcine pancreatic elastase complexed with FR901277, a novel macrocyclic inhibitor of elastases, at 1.6 A resolution.
    Nakanishi I; Kinoshita T; Sato A; Tada T
    Biopolymers; 2000 Apr; 53(5):434-45. PubMed ID: 10738204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the predicted model of alpha-lytic protease with the x-ray structure.
    Delbaere LT; Brayer GD; James MN
    Nature; 1979 May; 279(5709):165-8. PubMed ID: 440424
    [No Abstract]   [Full Text] [Related]  

  • 34. Crystallization of a complex between an elastase-specific inhibitor elafin and porcine pancreatic elastase.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    J Mol Biol; 1993 Jul; 232(1):310-1. PubMed ID: 8331669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular evolution of proteolytic enzymes].
    Pfleiderer G; Zwilling R
    Naturwissenschaften; 1972 Sep; 59(9):396-405. PubMed ID: 4673734
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of the peptide CF3-Leu-Ala-NH-C6H4-CF3 (TFLA) with porcine pancreatic elastase. X-ray studies at 1.8 A.
    Li de la Sierra I; Papamichael E; Sakarellos C; Dimicoli JL; Prangé T
    J Mol Recognit; 1990 Feb; 3(1):36-44. PubMed ID: 2354062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of crystalline -chymotrypsin. V. The atomic structure of tosyl- -chymotrypsin at 2 A resolution.
    Birktoft JJ; Blow DM
    J Mol Biol; 1972 Jul; 68(2):187-240. PubMed ID: 5069789
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
    Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
    Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the stereochemistry of catalysis by serine proteases.
    Polgár L; Asbóth B
    J Theor Biol; 1974 Aug; 46(2):543-58. PubMed ID: 4420762
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure of crystalline methyl-chymotrypsin.
    Wright CS; Hess GP; Blow DM
    J Mol Biol; 1972 Jan; 63(2):295-303. PubMed ID: 4634509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.